ownitsafely
Back to recalls

FDARecalled Apr 22, 2026 · #D-0471-2026

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Hazard

Class II — temporary health risk

Be the first to hear about future recalls.

Add the things you own to a watchlist. We’ll alert you the moment one matches.

Get started, free

Description

Lack of Assurance of Sterility Classification: Class II Distribution: OR

Product details

Product
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Type
Drugs
Manufacturer
PAYLESS COMPOUNDERS, LLC
Model numbers
01-27-2026
UPCs